Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein

Bodovitz, Steven; Klein, William L.

doi:10.1074/jbc.271.8.4436

Cited by 359

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein

Bodovitz, Steven, Klein, William L.·1996·Journal of Biological Chemistry

DOI 10.1074/jbc.271.8.4436

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.271.8.4436

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cholesterol may affect β-amyloidosis by modulating the proteolytic processing of APP and/or subsequent amyloid formation and deposition.
“Cholesterol may affect β-amyloidosis by modulating the proteolytic processing of APP and/or subsequent amyloid formation and deposition [9], [46].”
From ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage (2011) · cites this paper as [46]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981

Flagged first, then by citations

Research works printed but not linked: 49

Anderson, 1991, Neurosci. Lett., 128, 126, 10.1016/0304-3940(91)90775-O · DOI
Anderson, 1992, J. Neurochem., 59, 2328, 10.1111/j.1471-4159.1992.tb10128.x · DOI
Araki, 1991, Biochem. Biophys. Res. Commun., 181, 265, 10.1016/S0006-291X(05)81412-3 · DOI
Bodovitz, 1995, J. Neurochem., 64, 307, 10.1046/j.1471-4159.1995.64010307.x · DOI
Buxbaum, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 10075, 10.1073/pnas.89.21.10075 · DOI
Caporaso, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 3055, 10.1073/pnas.89.7.3055 · DOI
Caporaso, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 2252, 10.1073/pnas.89.6.2252 · DOI
Corder, 1993, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
Craido, 1982, Biochemistry, 21, 3622, 10.1021/bi00258a015 · DOI
De Caprio, 1992, J. Lipid Res., 33, 441, 10.1016/S0022-2275(20)41534-2 · DOI
De Strooper, 1993, J. Cell Biol., 121, 295, 10.1083/jcb.121.2.295 · DOI
Esch, 1990, Science, 248, 1122, 10.1126/science.2111583 · DOI
Ferreira, 1993, Science, 13, 3112
Fong, 1986, Biochemistry, 25, 830, 10.1021/bi00352a015 · DOI
Gillespie, 1992, Biochem. Biophys. Res. Commun., 187, 1285, 10.1016/0006-291X(92)90442-N · DOI
Glenner, 1984, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
Greenburg, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 7104, 10.1073/pnas.91.15.7104 · DOI
Grunze, 1980, Biochim. Biophys. Acta, 600, 860, 10.1016/0005-2736(80)90489-7 · DOI
Haass, 1992, Nature, 357, 500, 10.1038/357500a0 · DOI
Heron, 1980, Proc. Natl. Acad. Sci. U. S. A., 77, 7463, 10.1073/pnas.77.12.7463 · DOI
Irie, 1992, J. Pharm. Sci., 81, 521, 10.1002/jps.2600810609 · DOI
Irie, 1992, J. Pharm. Sci., 81, 524, 10.1002/jps.2600810610 · DOI
Jaffe, 1994, J. Biol. Chem., 269, 13065, 10.1016/S0021-9258(17)36796-0 · DOI
Lasa, 1991, Endocrinology, 132, 1701, 10.1210/endo.132.4.8462470 · DOI
LeBlanc, 1992, J. Neurosci. Res., 31, 635, 10.1002/jnr.490310407 · DOI
Masters, 1985, Proc. Natl. Acad. Sci. U. S. A., 82, 4245, 10.1073/pnas.82.12.4245 · DOI · Paper page
Mattson, 1993, Neuron, 10, 243, 10.1016/0896-6273(93)90315-I · DOI · Paper page
Mitchell, 1990, Biochemistry, 29, 9143, 10.1021/bi00491a007 · DOI
Ninomiya, 1993, J. Cell Biol., 121, 879, 10.1083/jcb.121.4.879 · DOI
Nishimoto, 1993, Nature, 362, 75, 10.1038/362075a0 · DOI
Nitsch, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 5191, 10.1073/pnas.90.11.5191 · DOI · Paper page
Palmert, 1992, Proc. Natl. Acad. Sci. U. S. A., 86, 6338, 10.1073/pnas.86.16.6338 · DOI
Pirtilia, 1995, J. Neurol. Sci., 127, 90, 10.1016/0022-510X(94)90140-6 · DOI
Poirier, 1993, Neuroscience, 55, 81, 10.1016/0306-4522(93)90456-P · DOI
Saunders, 1993, Lancet, 342, 710, 10.1016/0140-6736(93)91709-U · DOI
Schagger, 1987, Anal. Biochem., 166, 368, 10.1016/0003-2697(87)90587-2 · DOI
Schubert, 1989, Biochem. Biophys. Res. Commun., 162, 83, 10.1016/0006-291X(89)91965-7 · DOI
Seubert, 1993, Nature, 361, 260, 10.1038/361260a0 · DOI
Sing, 1985, Am. J. Hum. Genet., 37, 268
Sisodia, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 6075, 10.1073/pnas.89.13.6075 · DOI
Sparks, 1990, Neurobiol. Aging, 11, 601, 10.1016/0197-4580(90)90024-T · DOI
Sparks, 1993, J. Neuropathol. Exp. Neurol., 52, 135, 10.1097/00005072-199303000-00006 · DOI
Sparks, 1994, Exp. Neurol., 126, 88, 10.1006/exnr.1994.1044 · DOI · Paper page
Strittmatter, 1993, Proc. Natl. Acad. Sci. U. S. A., 269, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
Usami, 1993, J. Neurochem., 61, 239, 10.1111/j.1471-4159.1993.tb03560.x · DOI
Utermann, 1994, Curr. Biol., 4, 362, 10.1016/S0960-9822(00)00081-6 · DOI
Wang, 1991, J. Biol. Chem., 266, 16960, 10.1016/S0021-9258(18)55397-7 · DOI
Weidemann, 1989, Cell, 57, 115, 10.1016/0092-8674(89)90177-3 · DOI
Yeagle, 1991, Biochimie (Paris), 73, 1303, 10.1016/0300-9084(91)90093-G · DOI

Sorted by citations

The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Brain Cholesterol: Long Secret Life Behind a Barrier
Björkhem, I., & Meaney, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000120374.59826.1b · Cited by 1,044
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
Kojro, E., Gimpl, G., Lammich, S., März, W., & Fahrenholz, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081612998 · Cited by 804
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, H. H., Doody, R. S., Kivipelto, M., Sparks, D. L., Waters, D. D., Jones, R. W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6476a · Cited by 438
Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover
Lund, E. G., Xie, C., Kotti, T., Turley, S. D., Dietschy, J. M., & Russell, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303415200 · Cited by 421
Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
Vance, J. E. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010124 · Cited by 342
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target
Ye, S., Huang, Y., Müllendorff, K., Dong, L., Giedt, G., Meng, E. C., Cohen, F. E., Kuntz, I. D., Weisgraber, K. H., & Mahley, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508693102 · Cited by 275
Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests
Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., & Martins, R. N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.96 · Cited by 247
Mechanisms of Statin-mediated Inhibition of Small G-protein Function
Cordle, A., Koenigsknecht-Talboo, J., Wilkinson, B., Limpert, A., & Landreth, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505268200 · Cited by 235
The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease
Hirsch-Reinshagen, V., Maia, L. F., Burgess, B. L., Blain, J.-F., Naus, K. E., McIsaac, S. A., Parkinson, P. F., Chan, J. Y., Tansley, G. H., Hayden, M. R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508781200 · Cited by 233
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Feringa, F. M., & van der Kant, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690372 · Cited by 226
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub2 · Cited by 193
Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain
Lütjohann, D., Brzezinka, A., Barth, E., Abramowski, D., Staufenbiel, M., von Bergmann, K., Beyreuther, K., Multhaup, G., & Bayer, T. A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200071-jlr200 · Cited by 158
Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK
Pedrini, S., Carter, T. L., Prendergast, G., Petanceska, S., Ehrlich, M. E., & Gandy, S. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020018 · Cited by 154
Disease modifying therapy for AD?1
Golde, T. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04211.x · Cited by 117
Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods
Fonteh, A. N., Harrington, R. J., Huhmer, A. F., Biringer, R. G., Riggins, J. N., & Harrington, M. G. (2006) · Disease Markers · doi:10.1155/2006/202938 · Cited by 113
Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice
Cao, D., Fukuchi, K.-I., Wan, H., Kim, H., & Li, L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.011 · Cited by 106
Steroidogenic acute regulatory protein in the rat brain: cellular distribution, developmental regulation and overexpression after injury
Sierra, A., Lavaque, E., Perez‐Martin, M., Azcoitia, I., Hales, D. B., & Garcia‐Segura, L. M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02872.x · Cited by 98
Role of amyloid beta in lipid homeostasis
Grösgen, S., Grimm, M. O. W., Frieß, P., & Hartmann, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.002 · Cited by 90
Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan
Halford, R. W., & Russell, D. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813349106 · Cited by 75
Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease
Hirsch-Reinshagen, V., & Wellington, C. L. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32813aeabf · Cited by 61
Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism
Lukiw, W. J., Pappolla, M., Pelaez, R. P., & Bazan, N. G. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-4010-6 · Cited by 59
A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58
Risk factors for Azheimer’s disease during aging. Impacts of glucose/energy metabolism
Hoyer, S. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-7508-8_18 · Cited by 55
Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus
Akram, A., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.006 · Cited by 50
Cognitive Performance and Plasma Levels of Homocysteine, Vitamin B12, Folate and Lipids in Patients with Alzheimer Disease
Li, L., Cao, D., Desmond, R., Rahman, A., Lah, J. J., Levey, A. I., & Zamrini, E. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000164271 · Cited by 45
LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease
Abisambra, J. F., Fiorelli, T., Padmanabhan, J., Neame, P., Wefes, I., & Potter, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008556 · Cited by 42
Anti-amyloidogenic effect of Allium sativum in Alzheimer’s transgenic model Tg2576
Chauhan, N. B. (2003) · Journal of Herbal Pharmacotherapy · doi:10.1080/j157v03n01_05 · Cited by 39
ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage
Ramírez, C., Sierra, S., Tercero, I., Vázquez, J. A., Pineda, A., Manrique, T., & Burgos, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022712 · Cited by 31
Use of Genetic Variation as Biomarkers for Alzheimer's Disease
Reitz, C., & Mayeux, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04945.x · Cited by 24
Cyclopamine Modulates γ-Secretase-mediated Cleavage of Amyloid Precursor Protein by Altering Its Subcellular Trafficking and Lysosomal Degradation
Vorobyeva, A. G., Lee, R., Miller, S., Longen, C., Sharoni, M., Kandelwal, P. J., Kim, F. J., Marenda, D. R., & Saunders, A. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591792 · Cited by 16

Authors: Bodovitz, S., & Klein, W. L.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1996-02
Volume: 271
Issue: 8
Pages: 4436-4440
ISSN: 0021-9258
DOI: 10.1074/jbc.271.8.4436
Cited by: 359
References: 2
Language: en
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 9050 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks